Uncharacterized Protein, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | yes | yes: 3 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: A4HY74
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 394 | 398 | PF00656 | 0.554 |
CLV_NRD_NRD_1 | 100 | 102 | PF00675 | 0.454 |
CLV_NRD_NRD_1 | 138 | 140 | PF00675 | 0.487 |
CLV_NRD_NRD_1 | 211 | 213 | PF00675 | 0.554 |
CLV_NRD_NRD_1 | 214 | 216 | PF00675 | 0.528 |
CLV_NRD_NRD_1 | 255 | 257 | PF00675 | 0.518 |
CLV_NRD_NRD_1 | 357 | 359 | PF00675 | 0.502 |
CLV_NRD_NRD_1 | 360 | 362 | PF00675 | 0.478 |
CLV_NRD_NRD_1 | 66 | 68 | PF00675 | 0.623 |
CLV_PCSK_FUR_1 | 212 | 216 | PF00082 | 0.660 |
CLV_PCSK_FUR_1 | 358 | 362 | PF00082 | 0.527 |
CLV_PCSK_FUR_1 | 60 | 64 | PF00082 | 0.722 |
CLV_PCSK_KEX2_1 | 213 | 215 | PF00082 | 0.582 |
CLV_PCSK_KEX2_1 | 357 | 359 | PF00082 | 0.536 |
CLV_PCSK_KEX2_1 | 360 | 362 | PF00082 | 0.515 |
CLV_PCSK_KEX2_1 | 480 | 482 | PF00082 | 0.681 |
CLV_PCSK_KEX2_1 | 62 | 64 | PF00082 | 0.717 |
CLV_PCSK_KEX2_1 | 66 | 68 | PF00082 | 0.673 |
CLV_PCSK_KEX2_1 | 99 | 101 | PF00082 | 0.458 |
CLV_PCSK_PC1ET2_1 | 213 | 215 | PF00082 | 0.636 |
CLV_PCSK_PC1ET2_1 | 480 | 482 | PF00082 | 0.692 |
CLV_PCSK_PC1ET2_1 | 62 | 64 | PF00082 | 0.666 |
CLV_PCSK_SKI1_1 | 144 | 148 | PF00082 | 0.485 |
CLV_PCSK_SKI1_1 | 250 | 254 | PF00082 | 0.678 |
CLV_PCSK_SKI1_1 | 323 | 327 | PF00082 | 0.465 |
CLV_PCSK_SKI1_1 | 332 | 336 | PF00082 | 0.441 |
CLV_PCSK_SKI1_1 | 38 | 42 | PF00082 | 0.521 |
CLV_PCSK_SKI1_1 | 45 | 49 | PF00082 | 0.526 |
CLV_PCSK_SKI1_1 | 484 | 488 | PF00082 | 0.737 |
CLV_PCSK_SKI1_1 | 94 | 98 | PF00082 | 0.435 |
DEG_APCC_DBOX_1 | 128 | 136 | PF00400 | 0.416 |
DEG_SCF_TRCP1_1 | 3 | 8 | PF00400 | 0.575 |
DOC_MAPK_gen_1 | 348 | 356 | PF00069 | 0.444 |
DOC_MAPK_gen_1 | 445 | 454 | PF00069 | 0.594 |
DOC_MAPK_gen_1 | 462 | 469 | PF00069 | 0.539 |
DOC_MAPK_MEF2A_6 | 348 | 356 | PF00069 | 0.514 |
DOC_MAPK_RevD_3 | 467 | 481 | PF00069 | 0.470 |
DOC_PP1_RVXF_1 | 157 | 164 | PF00149 | 0.445 |
DOC_PP1_RVXF_1 | 176 | 183 | PF00149 | 0.502 |
DOC_PP2B_LxvP_1 | 288 | 291 | PF13499 | 0.460 |
DOC_PP2B_LxvP_1 | 47 | 50 | PF13499 | 0.621 |
DOC_PP4_FxxP_1 | 48 | 51 | PF00568 | 0.677 |
DOC_USP7_UBL2_3 | 140 | 144 | PF12436 | 0.500 |
LIG_14-3-3_CanoR_1 | 103 | 109 | PF00244 | 0.423 |
LIG_14-3-3_CanoR_1 | 149 | 155 | PF00244 | 0.517 |
LIG_14-3-3_CanoR_1 | 365 | 374 | PF00244 | 0.524 |
LIG_14-3-3_CanoR_1 | 484 | 489 | PF00244 | 0.622 |
LIG_Actin_WH2_2 | 89 | 105 | PF00022 | 0.523 |
LIG_BIR_III_4 | 228 | 232 | PF00653 | 0.516 |
LIG_CaM_IQ_9 | 116 | 131 | PF13499 | 0.521 |
LIG_CaM_IQ_9 | 173 | 189 | PF13499 | 0.420 |
LIG_CaM_IQ_9 | 349 | 365 | PF13499 | 0.474 |
LIG_eIF4E_1 | 42 | 48 | PF01652 | 0.548 |
LIG_EVH1_2 | 29 | 33 | PF00568 | 0.549 |
LIG_FHA_1 | 156 | 162 | PF00498 | 0.533 |
LIG_FHA_1 | 299 | 305 | PF00498 | 0.644 |
LIG_FHA_1 | 329 | 335 | PF00498 | 0.433 |
LIG_FHA_1 | 340 | 346 | PF00498 | 0.456 |
LIG_FHA_2 | 105 | 111 | PF00498 | 0.587 |
LIG_FHA_2 | 240 | 246 | PF00498 | 0.660 |
LIG_FHA_2 | 264 | 270 | PF00498 | 0.500 |
LIG_FHA_2 | 75 | 81 | PF00498 | 0.454 |
LIG_LIR_Apic_2 | 46 | 51 | PF02991 | 0.583 |
LIG_LIR_Gen_1 | 421 | 429 | PF02991 | 0.565 |
LIG_LIR_Nem_3 | 32 | 36 | PF02991 | 0.587 |
LIG_LIR_Nem_3 | 421 | 425 | PF02991 | 0.511 |
LIG_LIR_Nem_3 | 90 | 96 | PF02991 | 0.532 |
LIG_PCNA_yPIPBox_3 | 81 | 93 | PF02747 | 0.472 |
LIG_PTAP_UEV_1 | 428 | 433 | PF05743 | 0.557 |
LIG_SH2_CRK | 422 | 426 | PF00017 | 0.557 |
LIG_SH2_CRK | 434 | 438 | PF00017 | 0.494 |
LIG_SH2_GRB2like | 71 | 74 | PF00017 | 0.581 |
LIG_SH2_NCK_1 | 422 | 426 | PF00017 | 0.621 |
LIG_SH2_SRC | 471 | 474 | PF00017 | 0.704 |
LIG_SH2_STAP1 | 71 | 75 | PF00017 | 0.552 |
LIG_SH2_STAT3 | 190 | 193 | PF00017 | 0.509 |
LIG_SH2_STAT5 | 150 | 153 | PF00017 | 0.512 |
LIG_SH2_STAT5 | 190 | 193 | PF00017 | 0.448 |
LIG_SH2_STAT5 | 338 | 341 | PF00017 | 0.433 |
LIG_SH2_STAT5 | 468 | 471 | PF00017 | 0.621 |
LIG_SH3_3 | 23 | 29 | PF00018 | 0.604 |
LIG_SH3_3 | 255 | 261 | PF00018 | 0.590 |
LIG_SH3_3 | 426 | 432 | PF00018 | 0.598 |
LIG_SH3_3 | 47 | 53 | PF00018 | 0.603 |
LIG_WW_3 | 57 | 61 | PF00397 | 0.652 |
MOD_CK1_1 | 43 | 49 | PF00069 | 0.574 |
MOD_CK2_1 | 104 | 110 | PF00069 | 0.562 |
MOD_CK2_1 | 263 | 269 | PF00069 | 0.492 |
MOD_CK2_1 | 292 | 298 | PF00069 | 0.543 |
MOD_CK2_1 | 74 | 80 | PF00069 | 0.452 |
MOD_GlcNHglycan | 237 | 242 | PF01048 | 0.576 |
MOD_GlcNHglycan | 285 | 288 | PF01048 | 0.437 |
MOD_GlcNHglycan | 3 | 6 | PF01048 | 0.586 |
MOD_GlcNHglycan | 397 | 401 | PF01048 | 0.564 |
MOD_GSK3_1 | 1 | 8 | PF00069 | 0.594 |
MOD_GSK3_1 | 144 | 151 | PF00069 | 0.426 |
MOD_GSK3_1 | 319 | 326 | PF00069 | 0.454 |
MOD_GSK3_1 | 328 | 335 | PF00069 | 0.386 |
MOD_N-GLC_2 | 19 | 21 | PF02516 | 0.578 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.644 |
MOD_NEK2_1 | 15 | 20 | PF00069 | 0.715 |
MOD_NEK2_1 | 319 | 324 | PF00069 | 0.517 |
MOD_NEK2_1 | 339 | 344 | PF00069 | 0.291 |
MOD_NEK2_1 | 396 | 401 | PF00069 | 0.550 |
MOD_PIKK_1 | 263 | 269 | PF00454 | 0.627 |
MOD_PKA_2 | 148 | 154 | PF00069 | 0.401 |
MOD_PKA_2 | 283 | 289 | PF00069 | 0.515 |
MOD_PKB_1 | 330 | 338 | PF00069 | 0.472 |
MOD_PKB_1 | 363 | 371 | PF00069 | 0.555 |
MOD_Plk_1 | 87 | 93 | PF00069 | 0.528 |
MOD_Plk_4 | 473 | 479 | PF00069 | 0.549 |
MOD_SUMO_for_1 | 385 | 388 | PF00179 | 0.539 |
MOD_SUMO_rev_2 | 292 | 301 | PF00179 | 0.612 |
MOD_SUMO_rev_2 | 368 | 372 | PF00179 | 0.542 |
TRG_ENDOCYTIC_2 | 37 | 40 | PF00928 | 0.664 |
TRG_ENDOCYTIC_2 | 422 | 425 | PF00928 | 0.604 |
TRG_ENDOCYTIC_2 | 434 | 437 | PF00928 | 0.502 |
TRG_ER_diArg_1 | 130 | 133 | PF00400 | 0.448 |
TRG_ER_diArg_1 | 212 | 215 | PF00400 | 0.542 |
TRG_ER_diArg_1 | 356 | 358 | PF00400 | 0.510 |
TRG_ER_diArg_1 | 359 | 361 | PF00400 | 0.493 |
TRG_ER_diArg_1 | 363 | 366 | PF00400 | 0.483 |
TRG_ER_diArg_1 | 65 | 67 | PF00400 | 0.706 |
TRG_ER_diArg_1 | 99 | 101 | PF00400 | 0.458 |
TRG_NLS_MonoCore_2 | 211 | 216 | PF00514 | 0.624 |
TRG_NLS_MonoExtC_3 | 211 | 216 | PF00514 | 0.624 |
TRG_NLS_MonoExtN_4 | 209 | 216 | PF00514 | 0.555 |
TRG_Pf-PMV_PEXEL_1 | 100 | 104 | PF00026 | 0.443 |
TRG_Pf-PMV_PEXEL_1 | 106 | 110 | PF00026 | 0.442 |
TRG_Pf-PMV_PEXEL_1 | 189 | 193 | PF00026 | 0.503 |
TRG_Pf-PMV_PEXEL_1 | 250 | 254 | PF00026 | 0.678 |
TRG_Pf-PMV_PEXEL_1 | 332 | 337 | PF00026 | 0.520 |
TRG_Pf-PMV_PEXEL_1 | 348 | 353 | PF00026 | 0.434 |
TRG_Pf-PMV_PEXEL_1 | 393 | 397 | PF00026 | 0.507 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I9S0 | Leptomonas seymouri | 50% | 82% |
A0A1X0P7R9 | Trypanosomatidae | 33% | 95% |
A0A3S7WVD7 | Leishmania donovani | 100% | 87% |
A0A422P367 | Trypanosoma rangeli | 34% | 100% |
A4HA10 | Leishmania braziliensis | 69% | 100% |
D0A0J3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 35% | 100% |
E9AS04 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 82% | 100% |
Q4QDG9 | Leishmania major | 90% | 100% |
V5BSD1 | Trypanosoma cruzi | 36% | 100% |